005239064	005239064	CD	B-NP	O
|	|	NN	I-NP	O
SH	SH	NN	I-NP	O
|	|	NN	I-NP	O
66742680	66742680	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2880615	2880615	CD	B-NP	O
|	|	CC	I-NP	O
4/13/2005	4/13/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHEST	CHEST	NNP	I-NP	I-protein
PAIN	PAIN	NNP	I-NP	I-protein
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/19/2005	5/19/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/26/2005	10/26/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
LANGLAIS	LANGLAIS	NN	B-NP	O
,	,	,	O	O
EZEQUIEL	EZEQUIEL	NNP	B-NP	O
MD	MD	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
66-year-old	66-year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
two	two	CD	B-NP	O
prior	prior	JJ	I-NP	O
MIs	MI	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
LAD	LAD	NN	I-NP	O
stent	stent	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
presents	present	VBZ	B-VP	O
now	now	RB	B-ADVP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
when	when	WRB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
while	while	IN	B-SBAR	O
walking	walk	VBG	B-VP	O
and	and	CC	O	O
lasted	last	VBD	B-VP	O
2-3	2-3	CD	B-NP	O
hours	hour	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
relieved	relieve	VBN	I-VP	O
by	by	IN	B-PP	O
rest	rest	NN	B-NP	O
and	and	CC	O	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
diaphoresis	diaphoresis	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
Renba	Renba	NNP	B-NP	O
Memorial	Memorial	NNP	I-NP	O
Urgent	Urgent	NNP	I-NP	O
Care	Care	NNP	I-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
and	and	CC	O	O
sent	send	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Crossdick	Crossdick	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Of	Of	IN	B-PP	O
emergency	emergency	NN	B-NP	O
department	department	NN	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
troponin	troponin	NN	I-NP	O
of	of	IN	B-PP	O
5.6	5.6	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
peaked	peak	VBD	B-VP	O
at	at	IN	B-PP	O
6.7	6.7	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
diffuse	diffuse	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
evaluated	evaluate	VBN	I-VP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
surgical	surgical	JJ	I-NP	O
intervention	intervention	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Hypertension	Hypertension	NN	B-NP	O
,	,	,	O	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
B12	B12	NN	B-NP	B-protein
deficiency	deficiency	NN	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
CPAP	CPAP	NN	I-NP	O
,	,	,	O	O
nephrolithiasis	nephrolithiasis	NN	B-NP	O
,	,	,	O	O
restless	restless	JJ	B-NP	O
legs	leg	NNS	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
diabetic	diabetic	JJ	B-NP	O
retinopathy	retinopathy	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Congenital	Congenital	NNP	B-NP	O
Schatzki	Schatzki	NNP	I-NP	O
's	's	POS	B-NP	O
ring	ring	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
dilation	dilation	NN	I-NP	O
via	via	IN	B-PP	O
EGD	EGD	NN	B-NP	B-protein
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Positive	Positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
rare	rare	JJ	I-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
three	three	CD	B-NP	O
children	child	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
semi-retired	semi-retired	JJ	B-ADJP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
architect	architect	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Sulfa	Sulfa	NN	B-NP	O
causing	cause	VBG	B-VP	O
rash	rash	NN	B-NP	O
and	and	CC	O	O
joint	joint	JJ	B-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
enalaprilat	enalaprilat	NN	B-NP	O
causing	cause	VBG	B-VP	O
cough	cough	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Lopressor	Lopressor	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
valsartan	valsartan	NN	B-NP	O
160	160	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
atorvastatin	atorvastatin	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
B12	B12	NN	B-NP	B-protein
100	100	CD	I-NP	I-protein
mcg	mcg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
folate	folate	NN	B-NP	O
,	,	,	O	O
Levoxyl	Levoxyl	NNP	B-NP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
NovoLog	NovoLog	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
Height	Height	NNP	B-NP	O
5	5	CD	B-NP	O
feet	foot	NNS	I-NP	O
7	7	CD	B-NP	O
inches	inch	NNS	I-NP	O
tall	tall	NN	B-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
67	67	CD	I-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
:	:	:	O	O
Not	Not	RB	B-ADJP	O
listed	list	VBN	I-ADJP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
PERRL	PERRL	NN	B-NP	B-protein
.	.	.	O	O

Oropharynx	Oropharynx	NNP	B-NP	O
is	be	VBZ	B-VP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
:	:	:	O	O
Without	Without	IN	B-PP	O
carotid	carotid	NN	B-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
:	:	:	O	O
Without	Without	IN	B-PP	O
incisions	incision	NNS	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
.	.	.	O	O

Respiratory	Respiratory	JJ	B-ADJP	O
:	:	:	O	O
Breath	Breath	NN	B-NP	O
sounds	sound	NNS	I-NP	O
are	be	VBP	B-VP	O
clear	clear	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
incisions	incision	NNS	I-NP	O
,	,	,	O	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
masses	mass	NNS	I-NP	O
.	.	.	O	O

Rectal	Rectal	JJ	B-ADJP	O
:	:	:	O	O
Normal	Normal	JJ	B-NP	O
tone	tone	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
masses	mass	NNS	I-NP	O
,	,	,	O	O
guaiac	guaiac	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Without	Without	IN	B-PP	O
scarring	scar	VBG	B-NP	O
,	,	,	O	O
varicosities	varicosity	NNS	B-NP	O
or	or	CC	O	O
edema	edema	NN	B-NP	O
.	.	.	O	O

Pedal	Pedal	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
are	be	VBP	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Radial	Radial	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
are	be	VBP	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Allen	Allen	NNP	B-NP	O
's	's	POS	B-NP	O
test	test	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
is	be	VBZ	B-VP	O
normal	normal	JJ	B-ADJP	O
by	by	IN	B-PP	O
pulse	pulse	NN	B-NP	O
oximeter	oximeter	NN	I-NP	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
Alert	Alert	NNP	B-NP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
,	,	,	O	O
grossly	grossly	RB	B-NP	O
nonfocal	nonfocal	JJ	I-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
slightly	slightly	RB	B-NP	O
decreased	decrease	VBN	I-NP	O
light	light	NN	I-NP	O
touch	touch	NN	I-NP	O
sensation	sensation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
around	around	IN	B-PP	O
the	the	DT	B-NP	O
great	great	JJ	I-NP	O
toe	toe	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
VALUES	VALUES	VBZ	B-VP	O
ON	ON	NN	B-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
sodium	sodium	NN	B-NP	O
of	of	IN	B-PP	O
139	139	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
of	of	IN	B-PP	O
4.3	4.3	CD	B-NP	O
.	.	.	O	O

BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
12	12	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
1.2	1.2	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
glucose	glucose	NN	B-NP	O
of	of	IN	B-PP	O
106	106	CD	B-NP	O
.	.	.	O	O

Hematology	Hematology	NNP	B-NP	O
includes	include	VBZ	B-VP	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
7.4	7.4	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
33	33	CD	B-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
PTT	PTT	NN	B-NP	O
of	of	IN	B-PP	O
104	104	CD	B-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
data	datum	NNS	I-NP	O
:	:	:	O	O
EKG	EKG	NN	B-NP	B-protein
,	,	,	O	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
67	67	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
nonspecific	nonspecific	JJ	I-NP	O
T-wave	T-wave	NN	I-NP	O
abnormality	abnormality	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
aVL	aVL	NN	B-NP	O
,	,	,	O	O
V5	V5	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
V6	V6	NN	B-NP	B-protein
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
is	be	VBZ	B-VP	O
without	without	IN	B-PP	O
acute	acute	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
8/17/05	8/17/05	CD	B-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
mid	mid	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
and	and	CC	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
distal	distal	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
mid	mid	JJ	I-NP	O
LVB1	LVB1	NN	I-NP	O
,	,	,	O	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
mid	mid	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
,	,	,	O	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
D1	D1	NN	I-NP	O
,	,	,	O	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
PDA	PDA	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
dominant	dominant	JJ	I-NP	O
circulation	circulation	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
diffuse	diffuse	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
calcification	calcification	NN	I-NP	O
and	and	CC	O	O
extensive	extensive	JJ	B-NP	O
diffuse	diffuse	JJ	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
small	small	JJ	B-NP	O
distal	distal	JJ	I-NP	O
vessels	vessel	NNS	I-NP	O
.	.	.	O	O

LAD	LAD	NN	B-NP	O
in	in	IN	B-PP	O
stent	stent	JJ	B-NP	O
restenosis	restenosis	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
collateral	collateral	NN	B-NP	O
flow	flow	NN	I-NP	O
diffusely	diffusely	RB	B-NP	O
small	small	JJ	I-NP	O
left	left	JJ	I-NP	O
main	main	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
on	on	IN	B-PP	O
11/7/05	11/7/05	CD	B-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
CABG	CABG	NN	B-NP	B-protein
x4	x4	NN	I-NP	I-protein
with	with	IN	B-PP	O
SVG1	SVG1	NN	B-NP	B-protein
to	to	TO	B-PP	O
RCA	RCA	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
sequential	sequential	JJ	B-NP	O
graft	graft	NN	I-NP	O
of	of	IN	B-PP	O
SVG2	SVG2	NN	B-NP	B-protein
to	to	TO	B-PP	O
D1	D1	NN	B-NP	O
and	and	CC	B-NP	O
then	then	RB	I-NP	O
OM1	OM1	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
LIMA	LIMA	NN	B-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
LAD	LAD	NN	I-NP	O
endarterectomy	endarterectomy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Intensive	Intensive	JJ	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
following	follow	VBG	B-PP	O
surgery	surgery	NN	B-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
150	150	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Plavix	Plavix	NN	B-NP	O
on	on	IN	B-PP	O
arrival	arrival	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	B-DNA
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
dose	dose	NN	I-NP	O
6	6	CD	B-NP	O
hours	hour	NNS	I-NP	O
later	later	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	B-DNA
500	500	CD	B-NP	I-DNA
units	unit	NNS	I-NP	I-DNA
for	for	IN	B-PP	O
48	48	CD	B-NP	O
hours	hour	NNS	I-NP	O
and	and	CC	O	O
given	give	VBN	B-VP	O
aspirin	aspirin	NN	B-NP	O
that	that	IN	B-SBAR	O
same	same	JJ	B-NP	O
night	night	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
extubated	extubate	VBN	I-VP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
require	require	VB	I-VP	O
the	the	DT	B-NP	O
transfusion	transfusion	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

He	He	PRP	B-NP	O
required	require	VBD	B-VP	O
neosynephrine	neosynephrine	NN	B-NP	O
transiently	transiently	RB	B-ADVP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
off	off	RP	B-PRT	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

That	That	DT	B-NP	O
same	same	JJ	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
transferred	transfer	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Step-Down	Step-Down	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
,	,	,	O	O
neurologically	neurologically	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
,	,	,	O	O
with	with	IN	B-PP	O
pain	pain	NN	B-NP	O
well	well	RB	B-ADJP	O
controlled	controlled	JJ	I-ADJP	O
,	,	,	O	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
,	,	,	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Plavix	Plavix	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
transfer	transfer	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
chest	chest	NN	B-NP	O
tube	tube	NN	I-NP	O
in	in	IN	B-PP	O
that	that	DT	B-NP	O
still	still	RB	B-ADVP	O
had	have	VBD	B-VP	O
output	output	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
diet	diet	NN	I-NP	O
was	be	VBD	B-VP	O
being	be	VBG	I-VP	O
advanced	advance	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
being	be	VBG	I-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

Perioperatively	Perioperatively	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Diabetes	Diabetes	NNP	I-NP	O
Management	Management	NNP	I-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
control	control	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
from	from	IN	B-PP	O
IV	IV	CD	B-NP	O
insulin	insulin	NN	I-NP	O
to	to	TO	B-PP	O
subcutaneous	subcutaneous	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
postoperatively	postoperatively	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
preoperative	preoperative	JJ	I-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
of	of	IN	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
on	on	IN	B-PP	O
4/30/05	4/30/05	CD	B-NP	O
and	and	CC	O	O
treated	treat	VBN	B-VP	O
for	for	IN	B-PP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
wires	wire	NNS	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
tubes	tube	NNS	I-NP	O
and	and	CC	O	O
Foley	Foley	NNP	B-NP	O
were	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
loose	loose	JJ	B-NP	O
lower	low	JJR	I-NP	O
front	front	JJ	I-NP	O
teeth	tooth	NNS	I-NP	O
following	follow	VBG	B-PP	O
his	his	PRP$	B-NP	O
difficult	difficult	JJ	I-NP	O
intubation	intubation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
Dental	Dental	NNP	I-NP	O
Service	Service	NNP	I-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
recommendation	recommendation	NN	I-NP	O
was	be	VBD	B-VP	O
simply	simply	RB	B-ADVP	O
to	to	TO	B-VP	O
avoid	avoid	VB	I-VP	O
putting	put	VBG	I-VP	O
pressure	pressure	NN	B-NP	O
on	on	IN	B-PP	O
those	those	DT	B-NP	O
teeth	tooth	NNS	I-NP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
advised	advise	VBD	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
would	would	MD	B-VP	O
allow	allow	VB	I-VP	O
the	the	DT	B-NP	O
teeth	teeth	NN	I-NP	O
to	to	TO	B-VP	O
retighten	retighten	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
jaw	jaw	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
couple	couple	NN	I-NP	O
of	of	IN	B-PP	O
weeks	week	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
do	do	VB	I-VP	O
well	well	RB	B-ADVP	O
,	,	,	O	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
off	off	RP	B-PRT	O
oxygen	oxygen	NN	B-NP	O
,	,	,	O	O
saturating	saturate	VBG	B-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
progressed	progress	VBD	B-VP	O
daily	daily	RB	B-ADVP	O
and	and	CC	O	O
walked	walk	VBD	B-VP	O
first	first	RB	B-ADVP	O
with	with	IN	B-PP	O
assistance	assistance	NN	B-NP	O
and	and	CC	O	O
then	then	RB	O	O
steadily	steadily	RB	B-ADVP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
own	own	JJ	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
condition	condition	NN	I-NP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	B-protein
day	day	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
7	7	CD	I-NP	I-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
:	:	:	O	O
Enteric-coated	Enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
pain	pain	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
38	38	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
NovoLog	NovoLog	NNP	B-NP	O
18	18	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
NovoLog	NovoLog	NNP	B-NP	O
12	12	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
with	with	IN	B-PP	O
lunch	lunch	NN	B-NP	O
and	and	CC	I-NP	O
supper	supper	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
atorvastatin	atorvastatin	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Abusufait	Abusufait	NNP	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
surgeon	surgeon	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Cederberg	Cederberg	NNP	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
four	four	CD	B-NP	O
to	to	TO	I-NP	O
six	six	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
7-7992515	7-7992515	CD	B-NP	O
EMSFocus	EMSFocus	NN	I-NP	O
transcriptionists	transcriptionist	NNS	I-NP	O
Dictated	Dictate	VBD	B-VP	O
By	By	NNP	B-NP	O
:	:	:	O	O
GOTTDENGER	GOTTDENGER	NNP	B-NP	O
,	,	,	O	O
NEWTON	NEWTON	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ROTHERHAM	ROTHERHAM	NNP	B-NP	O
,	,	,	O	O
KENT	KENT	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
8838531	8838531	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/27/05	10/27/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/27/05	10/27/05	CD	B-NP	O

